(Q44053452)

29 November 2017

title

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder (English)

1 reference

29 November 2017

0 references

Michael W Otto

3

0 references

Steven A Safren

2

object named as

Steven A Safren

1 reference

29 November 2017

Naomi M Simon

1

1 reference

29 November 2017

Saumya G Sharma

4

1 reference

29 November 2017

Gretchen D Lanka

5

1 reference

29 November 2017

Mark H Pollack

6

1 reference

29 November 2017

publication date

1 May 2002

1 reference

Journal of Affective Disorders

29 November 2017

published in

1 reference

29 November 2017

volume

69

1 reference

29 November 2017

issue

1-3

1 reference

29 November 2017

page(s)

201-208

1 reference

Early coadministration of clonazepam with sertraline for panic disorder

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Long-term follow-up after a drug trial for panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

The Galway Study of Panic Disorder. III. Outcome at 5 to 6 years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

Is the course of panic disorder the same in women and men?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900359-7

7 January 2021

10.1016/S0165-0327(01)00359-7

Identifiers

DOI

1 reference

29 November 2017

1 reference